{"product_id":"cleveland-clinic-mellen-center-update-in-multiple-sclerosis-2025","title":"Cleveland Clinic Mellen Center Update in Multiple Sclerosis 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: meurologists, psychologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eHeld as a hybrid event, the course was designed to help clinicians navigate the rapidly changing landscape of MS care, moving from “active vs. non-active” disease classifications to a more nuanced understanding of “Smoldering MS” and Progression Independent of Relapse Activity (PIRA).\u003c\/p\u003e\n\u003cp\u003e2. What You Will Learn\u003c\/p\u003e\n\u003cp\u003eThe New Diagnostic Standard: A detailed breakdown of the 2024 McDonald Criteria, specifically how the integration of optic nerve involvement and radiologically isolated syndrome (RIS) changes early diagnosis.\u003c\/p\u003e\n\u003cp\u003e“Smoldering” MS: Understanding PIRA (Progression Independent of Relapse Activity) and how to identify patients who are getting worse despite having no new MRI lesions.\u003c\/p\u003e\n\u003cp\u003eEmerging Therapies: The latest data on BTK Inhibitors (Bruton’s Tyrosine Kinase) and their potential to treat progressive forms of the disease by targeting microglia.\u003c\/p\u003e\n\u003cp\u003eBiomarkers: The clinical utility of Serum Neurofilament Light Chain (sNfL) and the “Central Vein Sign” on MRI to differentiate MS from mimics.\u003c\/p\u003e\n\u003cp\u003eRehabilitation: Evidence-based protocols for high-intensity aerobic exercise and intermittent fasting as neuroprotective strategies.\u003c\/p\u003e\n\u003cp\u003e3. Event Details\u003c\/p\u003e\n\u003cp\u003eEvent: Mellen Center Update in Multiple Sclerosis (MS) 2025\u003c\/p\u003e\n\u003cp\u003eDate: June 20, 2025 (Friday)\u003c\/p\u003e\n\u003cp\u003eLocation: InterContinental Hotel and Conference Center, Cleveland, Ohio, USA.\u003c\/p\u003e\n\u003cp\u003eFormat: Hybrid (In-Person \u0026amp; Virtual Livestream).\u003c\/p\u003e\n\u003cp\u003eHost: Cleveland Clinic Mellen Center.\u003c\/p\u003e\n\u003cp\u003e4. Who Should Attend\u003c\/p\u003e\n\u003cp\u003eNeurologists: Specifically those treating general neurology patients who need to stay current with the new diagnostic criteria.\u003c\/p\u003e\n\u003cp\u003eAdvanced Practice Providers (NPs\/PAs): Who manage the long-term symptom burden of MS patients.\u003c\/p\u003e\n\u003cp\u003eRehabilitation Specialists (PT\/OT): Interested in the specific “Neurorestoration” track.\u003c\/p\u003e\n\u003cp\u003ePsychologists: Who manage the high prevalence of cognitive impairment and depression in this population.\u003c\/p\u003e\n\u003cp\u003e5. Why Attend\u003c\/p\u003e\n\u003cp\u003eMcDonald Criteria Authors: The Mellen Center faculty (including Dr. Daniel Ontaneda and Dr. Jeffrey Cohen) were key contributors to the international committee that revised the diagnostic criteria, offering attendees “primary source” explanations of the changes.\u003c\/p\u003e\n\u003cp\u003eComprehensive Care Model: Unlike purely pharmacological conferences, this course dedicates significant time to “Wellness” topics, including diet, exercise, and sleep, which are now considered standard disease-modifying interventions.\u003c\/p\u003e\n\u003cp\u003e6. Topics\u003c\/p\u003e\n\u003cp\u003e01 Keynote Cognitive Worsening in MS Cognitive Relapses and PIRA – Ralph Benedict\u003c\/p\u003e\n\u003cp\u003e02 Keynote Neurorestoration in MS Where We Stand Michelle Ploughman\u003c\/p\u003e\n\u003cp\u003e03 Updates to the McDonald Criteria The 2024 Revisions Daniel Ontaneda and Karlo Toljan\u003c\/p\u003e\n\u003cp\u003e04 Improving Access to Care in Multiple Sclerosis Marisa McGinley\u003c\/p\u003e\n\u003cp\u003e05 BTK Update What we are Learning from Phase 3 Data Robert Fox\u003c\/p\u003e\n\u003cp\u003e06 Managing Mood Disorders in MS – Amy Sullivan, Grace Tworek, Brianne Markley, Raghid Charara\u003c\/p\u003e\n\u003cp\u003e07 Emerging Treatment Paradigms for MOGAD in Adults and Children – Justin Abbatemarco and Aaron Abrams\u003c\/p\u003e\n\u003cp\u003e08 Women’s Health in Neuroimmunological Disorders Alise Carlson\u003c\/p\u003e\n\u003cp\u003e09 Practical Case Studies – Use of Imaging in the New Diagnostic Criteria – Moein Amin\u003c\/p\u003e\n\u003cp\u003e10 Applications of CAR-T in Multiple Sclerosis Jeffrey Cohen and Zarmina Javed\u003c\/p\u003e\n\u003cp\u003e11 Driving Safety in Multiple Sclerosis – How to Manage a Difficult Topic – Roundtable Discussion Rebecca Cebull, Jennifer Sedlak, and Timothy Verdouw\u003c\/p\u003e\n\u003cp\u003e12 Optic Neuritis Rehabilitation for the MS Patient Alyssa DeCarlo\u003c\/p\u003e\n\u003cp\u003e13 Approaching Dysarthria Dysphagia Challenges in MS Danielle Brown\u003c\/p\u003e\n\u003cp\u003e14 Central Dizziness Vestibular Based Rehab Support Kaitlin Sparks\u003c\/p\u003e\n\u003cp\u003e15 The Complex Clinical Picture of MS in Rehab A Case Report – Alyssa DeCarlo, Danielle Brown and Kaitlin Sparks\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405800231108,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Cleveland-Clinic-Mellen-Center-Update-in-Multiple-Sclerosis-2025.jpg?v=1784216347","url":"https:\/\/medicalcoursespro.com\/products\/cleveland-clinic-mellen-center-update-in-multiple-sclerosis-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}